Skip to main content
ConductScienceScienceDex
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

6,569

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

6,569 results for “Long-term”

Learn how ShareScore rates datasets ↗
zenodo16/100

Dataset related to article "Hypofractionated Whole Breast Irradiation and Simultaneous Integrated Boost in Large-breasted Patients: Long-term Toxicity and Cosmesis"s

<p>This record contains data related to article &quot;Hypofractionated Whole Breast Irradiation and Simultaneous Integrated Boost in Large-breasted Patients: Long-term Toxicity and Cosmesis&quot;</p> <p>Abstract</p> <p><strong>Introduction:&nbsp;</strong>The purpose of this study was to evaluate the impact of breast size on long-term toxicity and cosmesis in patients with breast cancer treated with hypofractionated simultaneous integrated boost (SIB) using volumetric modulated arc therapy (VMAT).</p> <p><strong>Patients and methods:&nbsp;</strong>Patients with early stage breast cancer were treated with 3-week hypofractionated SIB-VMAT to the whole breast (40.5 Gy) and tumor bed (48 Gy). Two cohorts were identified: small/medium- (&lt; 1000 cm<sup>3</sup>) and large- (&gt; 1000 cm<sup>3</sup>) breasted patients. Acute and late (at 2 and 5 years) skin toxicity and cosmetic data were analyzed. Univariate and multivariate analysis evaluated associations between toxicity and dosimetric/anatomical variables.</p> <p><strong>Results:&nbsp;</strong>From August 2010 to March 2017, a total of 1160 patients were treated; 831 had at least 2 years of follow-up and were analyzed. Treated skin area (TSA) receiving at least 20 Gy &gt; 400 cm<sup>2</sup>&nbsp;and V<sub>105% of Boost</sub>&nbsp;&gt; 5 cm<sup>3</sup>&nbsp;were significant predictors for acute skin toxicity. Multivariate analysis at 2 years was significant for boost volume &gt; 70 cm<sup>3</sup>, TSA &gt; 400 cm<sup>2</sup>, and breast size &gt; 1500 cm<sup>3</sup>. At 5 year analysis (352 patients), none of the analyzed variables was significant. For cosmetic outcome, only the breast size (&gt; 1000 cm<sup>3</sup>) and the boost size &gt; 70 cm<sup>3</sup>&nbsp;at 2 and 5 years, respectively, confirmed significance.</p> <p><strong>Conclusions:&nbsp;</strong>The TSA &gt; 400 cm<sup>2</sup>&nbsp;resulted as a significant predictor of both acute and late skin toxicity at 2 years; however, at 5 years, no breast size or dosimetric parameter suggested indications for increased toxicity. A worse cosmetic outcome was recorded at the 2-year follow up for large breasts, but was not confirmed at the 5-year follow-up. These long-term data suggest that hypofractionated SIB-VMAT is a viable modality also in large-breasted patients.</p>

restrictedFeb 2021View details →
zenodo16/100

Data for: Proteomics reveal biomarkers for diagnosis, disease activity and long-term disability outcomes in multiple sclerosis

<p>Protein levels were measured in cerebrospinal fluid samples (CSF; n = 186) and plasma samples (n = 165) from persons with multiple sclerosis and healthy controls. CSF samples and plasma samples were taken from 92 persons with CIS or RRMS at Link&ouml;ping University Hospital, Sweden and 51 persons with CIS or RRMS at the Karolinska University Hospital, Sweden. Everyone fulfilled the revised McDonald criteria from 2010 and 2017 for CIS or Multiple sclerosis (MS). Age-matched healthy controls (HC) were recruited from healthy blood donors (23 at the Link&ouml;ping University hospital and 20 at the Karolinska University Hospital). The concentration of 1463 proteins were measured using the Olink Explore platform which uses Proximity Extension Assay (PEA) technology. The proteins were preselected from four Olink panels: Explore 384 Cardiometabolic, Explore 384 Inflammation, Explore 384 Neurology, and Explore 384 Oncology. The protein concentrations are given as Olink&rsquo;s relative protein quantification unit on log2 scale: Normalized Protein Expression (NPX). The NPX values were intensity normalized by Olink.</p>

restrictedSep 2023View details →
zenodo16/100

Long-Term effects of natural chabazite zeolite on soil properties

<p>This dataset contains the results of analysis performed on soils amended with natural chabazite zeolite in comparison to unamended soil. The sampling was done 6 to 11 years after the application of natural zeolites, therefore is useful to investigate the long-term effects.&nbsp;</p> <p>Data refers to three experimental sites with different management (arable-cereal, perennial-pear and perennial-olive systems) in Italy.</p> <p>25 variables (including physical, chemical and biological) are included.</p> <p>&nbsp;</p> <p>This dataset was created in the framework of the project &ldquo;Uso dei geomateriali innovativi per un&rsquo;agricoltura sostenibile: impatto dei processi biotici e&nbsp;abiotici sul ciclo dell&rsquo;Azoto e applicazioni per il trattamento di acque&nbsp;grigie e reflui zootecnici&rdquo; (Grant 09-G-48651-5 F71B21005820007)</p>

restrictedcc-by-4.0Nov 2023View details →
zenodo16/100

Long-term stability of dental arch widths after extraction and non-extraction orthodontic treatment: a retrospective cohort study

<p>Dataset for all analyses. Initially, access will be granted to the editor and the peer reviewers. After acceptance, unrestricted access will be granted to everyone.</p>

restrictedcc-by-4.0Nov 2024View details →
zenodo16/100

Dataset related to article "Long-term outcomes after pancreatoduodenectomy for ampullary cancer: The influence of the histological subtypes and comparison with the other periampullary neoplasms"

<p>This record contains data related to article &quot;Long-term outcomes after pancreatoduodenectomy for ampullary cancer: The influence of the histological subtypes and comparison with the other periampullary neoplasms&quot;</p> <p><strong>Background. </strong>Ampullary carcinoma (AC) is histologically classified as intestinal (In-AC), pancreaticobiliary (Pb-AC) or mixed-AC. The prognostic role of AC subtypes has been debated and remains unclear. The aims of this study were to evaluate outcomes after pancreatoduodenectomy (PD) for each subtype of AC and to compare these with pancreatic ductal adenocarcinoma [PDAC] and distal cholangiocarcinoma [DCC].</p> <p><strong>Methods. </strong>PDs performed for AC between 2010-2018 were retrospectively evaluated. Histological subtype was obtained for all patients. One-year, 3-year and 5-year disease-free-survival (DFS) and overall survival (OS) rates were calculated. Kaplan-Meier survival analysis was performed to compare Pb-AC, In-AC and mixed-AC. Comparison with PDs performed for PDAC and DCC during the same period was also performed.</p> <p><strong>Results. </strong>A total of 97 patients undergoing PD for AC were evaluated: 34 (35.1%) In-AC, 54 (55.7%) Pb-AC and 9 mixed-AC (9.3%). DFS and OS rates for Pb-AC were significantly lower compared to In-AC (p&lt;0.05 and p&lt;0.01), but similar to mixed-AC (p=0.3 and p=0.4). Adjuvant therapy was not associated with increased survival, regardless of the histological subtype (p&gt;0.05). During the same period, 337 and 53 PDs for PDAC and DCC, respectively, were performed. In-AC was associated with significantly better outcomes compared to PDAC and DCC (p&lt;0.001); DFS and OS rates for Pb-AC and mixed AC were significantly higher compared to PDAC (p&lt;0.001), but similar to DCC (p&gt;0.05).</p> <p><strong>Conclusions. </strong>Pb-AC has significantly worse survival compared to In-AC. Moreover, mixed-AC should be considered as Pb-AC. Pb-AC and mixed-AC seem to have better prognosis compared to PDAC, but similar to DCC.</p>

restrictedJan 2022View details →
zenodo16/100

Long-term secondary cardiovascular prevention programme in patients subjected to coronary artery bypass surgery

<p>This record contains raw data related to the article: Long-term secondary cardiovascular prevention programme in patients subjected to coronary artery bypass surgery</p> <p>Abstract</p> <p><strong>Aims:&nbsp;</strong>Patients with coronary heart disease (CHD) are at very high risk of recurrent events. A strategy to reduce excess risk might be to deliver structured secondary prevention programmes, but their efficacy has been mostly evaluated in the short term and in experimental settings. This is a retrospective case-control study aimed at assessing, in the real world, the efficacy of a secondary prevention programme in reducing long-term coronary event recurrences after coronary artery bypass surgery (CABG).</p> <p><strong>Methods and results:&nbsp;</strong>Programme participants (henceforth &#39;cases&#39;) were men and women aged &lt;75 years subjected to CABG between 2002 and 2014, living within 100 km of the hospital. Key programme actions included optimization of treatments according to the most updated European preventive guidelines, surveillance of therapy adherence, and customized lifestyle counselling. Controls were analogous patients not involved in the programme because living farther than 100 km away, matched 1:1 with cases for gender, age at CABG, and year of CABG. Both groups (n = 1248) underwent usual periodic cardiology follow-up at our centre. Data on symptomatic or silent CHD recurrences were obtained from the hospital electronic health records. Cox analysis (adjusted for baseline differences between groups) shows that programme participation was associated with a significantly lower incidence throughout 5 years post-CABG of symptomatic [hazard ratio (95% confidence interval): 0.59 (0.38-0.94)] and silent [0.53 (0.31-0.89)] coronary recurrences.</p> <p><strong>Conclusion:&nbsp;</strong>In a real-world setting, taking part in a structured longstanding secondary prevention programme, in addition to usual cardiology care, meaningfully lowers the risk of coronary recurrences.</p>

restrictedNov 2020View details →
zenodo16/100

Dataset related to article "Long-Term Follow-Up of Patients with Metastatic Epidural Spinal Cord Compression from Solid Tumors Submitted for Surgery Followed by Radiation Therapy"

<p>This record contains raw data related to article &quot;Long-Term Follow-Up of Patients with Metastatic Epidural Spinal Cord Compression from Solid Tumors Submitted for Surgery Followed by Radiation Therapy&quot;</p> <p>OBJECTIVE:</p> <p>To evaluate the outcome of patients with epidural spinal cord compression from different solid tumors treated with a combined approach, surgery plus radiotherapy (RT), with a follow-up longer than 10 years.</p> <p>METHODS:</p> <p>Ninety-seven patients treated between 2002 and 2009 were included. Surgical treatment was performed in patients with good performance status, limited metastatic disease, life expectancy longer than 3 months, and progressive neurologic deficit and/or intractable pain. RT was performed delivering a median total dose of 30 Gy in 10 fractions. Clinical outcome was evaluated using the modified visual analog scale for pain, the Frankel scale for neurologic deficit, and magnetic resonance imaging before treatment, after treatment, and every 3 months thereafter.</p> <p>RESULTS:</p> <p>Palliative decompression was performed in 27% of patients, tumor curettage (debulking) was performed in 51%, and total vertebrectomy was performed in 22%, followed by RT in 78% of cases. Pain remission was obtained in 98% of patients, and recovery of neurologic function was obtained in 51%. The median follow-up time was 135 months (range, 96-209 months). The 5- and 10-year local control rates were 82.8% and 82.8%, respectively. The median and 5- and 10-year progression-free survival rates were 12 months, 16.9%, and 11.3%, respectively; the median and 5- and 10-year overall survival rates were 18 months, 21.3%, and 12%, respectively. On univariate and multivariate analysis, factors recorded as conditioning survival were the performance status and the presence of other metastases at the time of vertebral treatment (P &lt; 0.01).</p> <p>CONCLUSIONS:</p> <p>Our update confirmed that surgery plus RT is a safe and feasible treatment with limited morbidity. In selected patients with favorable prognostic factors, the combined treatment may significantly impact on survival.</p>

restrictedSep 2019View details →
zenodo16/100

Dataset related to article "Phase II trial on SBRT for unresectable liver metastases long-term outcome and prognostic factors of survival after 5 years of follow-up"

<p>This record contains raw data related to article &quot;Phase II trial on SBRT for unresectable liver metastases long-term outcome and prognostic factors of survival after 5 years of follow-up&quot;</p> <p>BACKGROUND:</p> <p>The aim of this study was to evaluate long-term efficacy and survival prognostic factors of stereotactic body radiation therapy (SBRT) for un-resectable liver metastases in patients enrolled in a prospective phase II trial.</p> <p>METHODS AND MATERIALS:</p> <p>5-year local control (LC), overall survival (OS), progression free survival (PFS) and toxicity rates were analyzed in patients with un-resectable liver metastases enrolled in a Phase II Trial on liver SBRT, with a prescription dose of 75Gy in 3 consecutive fractions.</p> <p>RESULTS:</p> <p>A total of 61 patients with 76 lesions were enrolled, with a median follow-up time of 6.1&thinsp;years. One, three and 5 year LC rates were 94&thinsp;&plusmn;&thinsp;3.1%, 78.0&thinsp;&plusmn;&thinsp;5.9% and 78.0&thinsp;&plusmn;&thinsp;5.9%, without reaching the median LC time. Median OS was 27.6&thinsp;months and the survival rates were 85.2&thinsp;&plusmn;&thinsp;4.5%, 31.1&thinsp;&plusmn;&thinsp;5.9% and 18.0&thinsp;&plusmn;&thinsp;4.9% at 1, 3 and 5-year after SBRT, respectively. Univariate analysis showed that favorable primary site (colorectal, breast and gynecological) of metastases (p&nbsp;=&thinsp;0.001) improved survival. Toxicity was moderate. One patient experienced G3 late chest wall pain, which resolved within 1&thinsp;year from SBRT. No cases of Radiation Induced Liver Disease (RILD) were detected.</p> <p>CONCLUSIONS:</p> <p>Long-term results of this Phase II study suggest the efficacy and safety of SBRT for un-resectable liver metastases after 5-year of follow up. Selection of cases with positive prognostic factors may improve long-term survival of these oligo-metastastic patients and may confirm the role of SBRT as an effective alternative local therapy for liver metastases.</p>

restrictedSep 2019View details →
zenodo16/100

Long-term knee health in adults with a history of adolescent Osgood-Schlatter: A cross-sectional follow-up on a national cohort of patients from secondary care in Denmark 1977-2020

Open the record for dataset details and reuse information.

restrictedcc-by-4.0Sep 2024View details →
zenodo16/100

ENGAGE post-Glasgow long-term strategies

<p><strong>Please do not request the download through Zenodo. Instead download the data set here: </strong><a href="https://data.ece.iiasa.ac.at/engage/#/downloads"><strong>https://data.ece.iiasa.ac.at/engage/#/downloads</strong></a><strong>.</strong></p><p>This set of scenarios integrates global pathways into a coherent set of low-carbon mid-century strategies, assessing current policies, NDCs and national mid-century strategies and their consistency with global pathways to 1.5/2°C warming levels and identifying the most effective policies in different countries and sectors.</p>

restrictedOct 2023View details →
zenodo16/100

25 new long-term variables in the GX 339-4 field: two years of MeerKAT monitoring

<p>These are the radio light curves for the 25 new long-term variable sources found in weekly ThunderKAT monitoring of the low-mass X-ray binary GX 339-4 with MeerKAT. These data are part of a publication submitted to Monthly Notices for the Royal Astronomical Society (Driessen et al., submitted) and part of Laura&#39;s Driessen PhD thesis (the jodrell Bank Centre for Astrophysics, the University of Manchester, UK).</p> <p>The observations are MeerKAT L-band observations. Each epoch is approximately 10-15 minutes long, these are the first two years of weekly monitoring, from September 2018 to the end of August 2020. The light curves have been extracted from the images using the <a href="https://tkp.readthedocs.io/en/latest/introduction.html">LOFAR Transients Pipeline (TraP)</a>.</p> <p>Each file contains the information for a single source. The files are formatted with columns as follows:</p> <ul> <li>mjd:&nbsp;the modified Julian Date (MJD) of the observation. The MJD is given by MJD=JD-2400000.5 where JD is the Julian Date</li> <li>f_int_median_scaled_Jy: the flux density of the source in Jansky (Jy) determined by the LOFAR TraP,&nbsp;after the systematic correction model has been applied&nbsp;(see Driessen et al. 2021)</li> <li>f_int_median_scaled_err_Jy: the uncertainty on&nbsp;f_int_median_scaled_Jy in Jansky determined by the&nbsp;LOFAR TraP, after the systematic correction model has been applied&nbsp;(see Driessen et al. 2021)</li> <li>freq_eff_Hz: the effect frequency in Hertz (Hz)</li> <li>median_scaled_eta: the chi squared variability parameter&nbsp;for the source in the specified frequency band/subband. This parameter is defined in Driessen et al. 2021, Swinbank et al. 2015 and on the <a href="https://tkp.readthedocs.io/en/latest/introduction.html">LOFAR TraP website</a></li> <li>median_scaled_V: the modulation variability parameter&nbsp;for the source in the specified frequency band/subband. This parameter is defined in Driessen et al. 2021, Swinbank et al. 2015 and on the <a href="https://tkp.readthedocs.io/en/latest/introduction.html">LOFAR TraP website</a></li> <li>name: this is the name of the source as&nbsp;defined in Driessen et al. 2021</li> <li>subband: this file contains the light curve of the source&nbsp;from multi-frequency synthesis (MFS) imaging of the full&nbsp;MeerKAT L-band (from 856 to 1712 MHz)&nbsp;epochs, plus 8 subband images with central frequencies: 909, 1016, 1123, 1230, 1337, 1444, 1551 and 1658 MHz. This column shows which subband or MFS the values in the row are from</li> </ul> <p>The files were made using the Pandas package, so we recommend Python users load them using&nbsp;</p> <pre><code class="language-python">import pandas as pd pd.read_csv(filename, comment='#') </code></pre> <p>If you use the data shared here please ensure that you&nbsp;cite the MNRAS paper (Driessen at al. submitted) and the Zenodo DOI:&nbsp;10.5281/zenodo.5069119.</p> <p>&nbsp;</p> <p>The MeerKAT telescope is operated by the South African Radio Astronomy Observatory, which is a facility of the National Research Foundation, an agency of the Department of Science and Innovation.<br> LND acknowledges support from the European Research Council (ERC) under the European Union&#39;s Horizon 2020 research and innovation programme (grant agreement No 694745).</p>

restrictedJul 2021View details →
zenodo16/100

Dataset related to article "Is testis sparing surgery safe in patients with incidental small testicular lesions referring to a fertility center? A retrospective analysis reporting factors correlated to malignancy and long-term oncological outcomes "

<p>This record contains raw data related to article &ldquo;Is testis sparing surgery safe in patients with incidental small testicular lesions referring to a fertility center? A retrospective analysis reporting factors correlated to malignancy and long-term oncological outcomes&quot;</p> <p>Abstract</p> <p><strong>Purpose: </strong> To define predictors of malignancy after Testis sparing surgery (TSS) in patients referring to a fertility center with incidental small testicular lesions. Sub analyses were performed to assess predictors of Leydig cell hyperplasia and Leydig cell tumor.</p> <p><strong>Materials and methods: </strong> We performed a retrospective analysis of a single institutional database including patients treated with TSS between 2002 and 2020. All patients who underwent TSS as a first line surgical approach for incidentally detected lesions found during fertility evaluation were included.</p> <p><strong>Results: </strong> Data of 64 patients were collected. The median follow up was 58 months and no recurrences were observed. At univariable logistic regression multifocal lesions, hypervascularization, microlithiasis, age and lesion size were significantly associated with malignancy. At multivariable logistic regression lesion dimension, hypervascularization and multifocal lesions were predictors of malignancy. Lesions smaller than 5 mm proved to be benign in 96.6% of the cases (32/33). Intraoperative color of the lesion and US pattern of vascularization were predictors at multivariable logistic regression for Leydig cell hyperplasia and Leydig cell tumor.</p> <p><strong>Conclusion: </strong> Ultrasonographic characteristics and intraoperative appearance of the lesion can predict the malignant nature of small testicular lesions, guiding their surgical management in patients referring to a fertility center. Based on our experience, clinicians may safely perform TSS in carefully selected patients.</p> <p>&nbsp;</p>

restrictedJan 2023View details →
ClinicalTrials.gov16/100

Long-Term Assessment of Safety and Physical Function With AMG 108 in RA

ClinicalTrials.gov study NCT00369473. IPD Sharing: Not stated. Countries: 0. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov16/100

Short-term Ketogenic Diet as Compared With Conventional Long-term Trial in Refractory Infantile Spasms: A Randomized, Controlled Study

ClinicalTrials.gov study NCT00968136. IPD Sharing: Not stated. Countries: 0. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov16/100

Long-Term Study of Cerebral Glucose Metabolism in Huntington's Disease

ClinicalTrials.gov study NCT00004753. IPD Sharing: Not stated. Countries: 0. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov16/100

Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Chronic Neuropathic Pain.

ClinicalTrials.gov study NCT00141362. IPD Sharing: Not stated. Countries: 0. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov16/100

To Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Postherpetic Neuralgia.

ClinicalTrials.gov study NCT00150436. IPD Sharing: Not stated. Countries: 0. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov16/100

Long-Term Predictors of Morbidity in Older Age

ClinicalTrials.gov study NCT00094263. IPD Sharing: Not stated. Countries: 0. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
geo16/100

Transcriptome data of bone marrow long-term hematopoietic stem cells (LT-HSCs) from mice with or without 3-month serine/glycine-free diet (SGFD) treatment.

GEO Series GSE249609. Mus musculus. 6 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenAug 2024View details →
geo16/100

Inhibiting neutrophils activation by long-term administration of 5-amino salicylic acid reduces colitis-associated colorectal tumor burden in ApcMin/+ mice

GEO Series GSE83749. Mus musculus. 16 samples. Type: Expression profiling by array.

openGEO-OpenJun 2019View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.